Imagine a simple, non-invasive way to find out if someone you love is just forgetful… or in the beginning stages of Alzheimer’s? What if a quick, test could relieve your mind, or lead them to prompt, correct medical treatment. Breathtec Biomedical Inc. is an innovative publicly traded company that could be one of the most lucrative opportunities in the market today.

FALSE ALZHIMER’S TEST

Country music legend Kris Kristofferson, who has battled memory problems for years, is apparently among many Americans who have been misdiagnosed with Alzheimer’s disease, only to learn later that they actually have a treatable illness – in this case, Lyme disease, a top expert says.” Newsmax Health June 25, 2016Screenshot 2016-06-26 20.35.15

A new technology opens the possibilities to test for cancer by simply breathing into a hand-sized device. In the future, you may never have to suffer through a colon, breast or lung biopsy.

Think of time and pain that could be saved if a quick breath test revealed a patient had pneumonia– in minutes– instead of waiting two long days to grow a culture.

In 1971, Nobel Prize laureate, Linus Pauling, detected Volatile Organic Compounds (VOC) on the breath. These light gasses disperse quickly into the air and occur in parts per million. They may or may not have an odor discernible to the human nose.

Screenshot 2016-06-26 20.35.44Doctors have known for years that you could smell a late stage disease on a patient’s breath. For example, a strong smell of acetone on the breath could indicate advanced diabetes. Now they understood they smelled VOC’s.

But scientists didn’t know what each VOC’s meant and how to determine where they came from. Some VOC’s come from outside sources—breathed in and then out. Others are produced within the body.

So while there was hope for a non-invasive diagnostic method, doctors still had to rely on traditional methods. However most tests have drawbacks. Most are:

  • Slow to get results. Tests for pneumonia can take 48 hours to process. Should doctors risk patients getting sicker or treating with antibiotics and creating more antibiotic resistant germs?
  • Invasive. Prostate, colon, or breast biopsy’s are invasive, costly and carry additional health dangers just to perform them.
  • Painful. Painful tests can compromise sick patients and put them further at risk.
  • Expensive. Tests need a doctor or hospital visit, laboratory, or complex equipment that drives up costs.
  • Limited availability. In April 2016, 1.8% of Britain’s NHS patients waited over 6 weeks for diagnostic care. Canada has not yet created an acceptable bench mark waiting time for some diagnostics, and the USA has been struggling with wait times for veteran’s care.

Poor Diagnostic Tests Drive up Medical Costslungs-detail

Problems with diagnostic tests sometimes leave patents delaying care. Then the disease may progress to late stages before discovery. A delayed diagnosis adds to patient suffering, increases the scope of treatment and may even lead to early death. Diagnostic delays also account for the most common and most costly malpractice claims.

And some diseases are still difficult to diagnose. Doctors must try a variety of tests, observe symptoms and come up with a probable diagnoses. Alzheimer’s, Parkinson’s, ovarian cancer, even some auto-immune diseases can be very hard to catch in the early stages.

A novel, break-through technology stands poised to change all this.

Lung Cancer Screening

CT Scan- 85% accurate

Time for test: About 45 minutes including questionnaire, undressing, laying on diagnostic table.

Time for results: 3-4 business days

Cost: $200-400

Risks: Large chance of false positives add worry and additional testing.

Breath Diagnostic- 95% accurate

Time- test and results: Few minutes

Cost: Under $50

Risk: Low risk of finding false abnormalities

Lung Cancer Screening

CT Scan- 85% accurate

Time for test: About 45 minutes including questionnaire, undressing, laying on diagnostic table.

Time for results: 3-4 business days

Cost: $200-400

Risks: Large chance of false positives add worry and additional testing.

Breath Diagnostic- 95% accurate

Time- test and results: Few minutes

Cost: Under $50

Risk: Low risk of finding false abnormalities

Even though scientists knew that diseases can be smelled on the breath, two limitations held back the advance of breath as a diagnostic tool.

  • Finding the specific volatile organic compounds (VOC) that make up the breath print or signature of a specific disease.
  • Creating a device sensitive enough to measure VOC’s that occur in only 0.1-10 particles per billion and then interpret the results correctly.

Years of research and the investment of millions of dollars are now paying off. Scientist and engineer, Professor Hossam Haick, has developed nano-technology that sniffs out microscopic amounts of VOC’s. His work at Technion-Israel Institute of Technology has garnered him dozens of international honors and prestigious prizes.

Haick invented the NA-NOSE which detects diseases by mechanically “smelling” the breath of patients. This specialized mass spectrometer is capable of categorizing VOC’s into disease signatures. This could be a massive breakthrough in a doctor’s daily practice.

Studies compare the breath of healthy patients with diseased ones to determine the VOC’s that are unique to each disease. For example, patients with lung cancer exhale 75 specific VOC’s that are different from healthy people.

Thus far, scientists have determined the VOC breath prints for:

  • lung and breast cancers
  • Alzheimer’s and Parkinson’s diseases
  • Tuberculosis
  • Diabetes
  • Liver disease
  • Streptococcus and MRSA
  • Pneumonia
  • Chickenpox
  • Flu and the common cold

And it can even tell if a disease is in its beginning or advanced state so doctors can best streamline treatment.

This NA-NOSE technology seems poised to dramatically change how we diagnose diseases. It can be used by non-specialists in out-patient settings and could bring significant cost savings to budget-strapped healthcare organizations.

“We are currently evaluating breath testing technologies from around the world to add to our intellectual property portfolio.”

Kal Malhi, President Breathtec

“We are currently evaluating breath testing technologies from around the world to add to our intellectual property portfolio.”

               -Kal Malhi, President Breathtec

Screenshot 2016-06-26 20.34.49Breathtec Biomedical, Inc. stands at the forefront of this new diagnostic technology. For the past several years, Breathtec has been quietly researching, finding, and licensing the best-in-class breath analysis diagnostic tools. They have teamed with renowned experts to commercialize the early screening of life-threatening diseases.

Breathtec aims to offer low-cost, non-invasive diagnostic testing with the goal of early detection of major cancers and life-altering diseases. They are proud to produce a technology that could result in major improvements in survivability and life quality.

TECHNION GIVES RESEARCHER MILLON DOLLAR LABS

“The Technion has great faith in Haick and his research. Haick’s labs employ 27 researchers and 14 technology developers. His team has registered 17 patents so far.” —Harretz June 15, 2016

Haick with nano-smelling technology

Breathtec has licensed the NA-NOSE technology and brought Professor Haick on board as a consultant. He will guide the clinical trials and company’s development of the breath technology. Known for his highest ethics, GOOD Magazine named Haick one of 100 of the world’s top contributors for his service to humanity.

Another world-renowned professor, Dr. Rick Yost from the University of Florida, has also joined Breathtec. He is the head of Analytical Chemistry and the Director for the National Institute of Health Southeast Center for Integrated Metabolomics. Yost’s patented triple quadruple mass spectrometer design has produced over $30 billion worth of instrument sales.

working-in-laboratoryYost will supervise the proprietary components required for hand held breath testing. Special components such as a high-voltage generator, non-radioactive ionization source, and array detector are being integrated with the novel high-Field Asymmetric waveform Ion Mobility Spectrometer (FAIMS) cell to provide the most technologically advanced FAIMS-based instrument in the world.

To enable Breathtec to capture a major piece of the diagnostic market, Malhi brought in Core Capital Partners. This venture capital firm manages $400 million and has invested in 70 start-up companies in emerging IT and health care technology.

Recently Breathtec advanced Mr. Guy LaTorre to Chief Executive Officer. He brings over 25 years of experience in developing and commercializing medical devices and consumer products for startup companies. He has authored or co-authored over 50 scientific publication and holds seven US patents with world-wide filings.

Formerly, as co-founder and Vice President of Business Development for Vovamin Technology, Inc., LaTorre created partnerships with industry leaders such as 3M Corp, Sultain Healthcare, and Dentsply Corp. In 2010 the company was sold to GlaxoSmithKline (GSK) for USD $135 million.

“I see growth potential in Breathtec that surpasses that of Vovamin Technology,” LaTorre said. “This technology is truly life-changing, and there’s nothing like it on the market.”

BTH LOGO - smallBreathtec Biomedical, Inc. stock can be found on the Canadian Securities Exchange (CSE: BTH), the CNSX Markets Inc. Exchange (CNSX: BTH), The Frankfort Exchange (FRANKFURT: BTI), and Over the Counter USA (OTCQB: BTHCF). Recent share price: USD $.26.